Illumina
概要

日付:
15th February 2024, Thursday

時間:
07:00 am - 08:00 am (Capetown)
08:00 am - 09:00 am (Istanbul)
09:00 am - 10:00 am (Dubai)
10:30 am - 11:30 am (Delhi)
01:00 pm - 02:00 pm (Singapore)
02:00 pm - 03:00 pm (Seoul / Tokyo)
03:00 pm - 04:00 pm (Melbourne)

Register Now
We understand that our webinar timing may not suit your busy schedule. Please feel free to register to get the on-demand recording link once it is ready.

Join Dr. Anthony Beckhouse, Senior Manager, Regional Product Marketing Systems Lead, Illumina, presenting all the exciting Illumina announcements from the 2024 Advances in Genome Biology and Technology (AGBT) General Meeting, including the latest Illumina sequencing innovations powered by XLEAP-SBS chemistry.

About AGBT:

The Advances in Genome Biology and Technology (AGBT) General Meeting held annually in Orlando, Florida (USA) is the preeminent genome science and technology conference for the top global researchers, leaders, and innovators to come together to share and exchange information about the latest advances in DNA sequencing technologies, experimental and analytical approaches for genomic studies, and their myriad applications. Learn more about AGBT at www.agbt.org.

  1. Features of XLEAP-SBS chemistry on NovaSeq X and quality updates
  2. Transition of XLEAP-SBS to the NextSeq 1000/2000 instruments
  3. Targeting extra coverage in challenging regions of the human genome.

Dr. Anthony Beckhouse
Senior Manager, Regional Product Marketing Systems Lead
Illumina

Anthony is a member of the Illumina Product Marketing team, representing and managing all Illumina Sequencing platforms and core consumables for the Asia, Middle East and Africa (AMEA) region. Over the last 10 years, he has held many roles in the biotech sales, technology development and technical support industry and has been the industry representative on several successful grant applications within Australia.